NATRECOR Side Effects

6375737-8 | Blood Pressure Decreased
on Sep 22, 2009 Female patient from UNITED STATES , 69 years of age, weighting 339.5 lb, was diagnosed with cardiac failure congestive and was treated with Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased. Natrecor dosage: 2 Mcg/kg Bolus Over 60 Sec Iv Bolus; 1 Mcg/kg Bolus Over 60 Sec Iv Bolus.

5934222-5 | Blood Creatinine Increased, Hypotension
Patient was taking Natrecor (View Usage). Patient had the following side effects: blood creatinine increased, hypotension on Oct 28, 2008 from UNITED STATES Additional patient health information: Male patient , 77 years of age, weighting 251.3 lb, was diagnosed with cardiac failure congestive and. Natrecor dosage: 1.5 Mg 6.5 Ml/hr Iv.

5506259-1 | Cardiac Arrest, Ejection Fraction Decreased, Hypotension, Pulmonary Arterial Wedge Pressure Decreased
Adverse event was reported on Oct 31, 2007 by a Male patient taking Natrecor (View Usage) (Dosage: ) was diagnosed with myocardial infarction, cardiac failure and. Location: COLOMBIA , 45 years of age, After Natrecor was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), ejection fraction decreased, hypotension, pulmonary arterial wedge pressure decreased. Patient was hospitalized and became disabled.

5488434-8 | Cardiac Failure
on Jan 24, 2007 Male patient from UNITED STATES , 86 years of age, weighting 170.0 lb, was diagnosed with cardiac failure congestive and was treated with Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure. Natrecor dosage: 2 Ug/kg, In 4 Hour, Intravenous. During the same period patient was treated with CAPTOPRIL (View Captopril Review and Captopril Label ), LASIX (View Lasix Review and Lasix Label ), COUMADIN (View Coumadin Review and Coumadin Label ).


5448618-1 | Blood Creatinine Increased, Blood Urea Increased, Post Procedural Complication
on Sep 06, 2007 Male patient from UNITED STATES , 82 years of age, was diagnosed with cardiac failure acute and was treated with Natrecor (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, post procedural complication. Natrecor dosage: 0.01 Mcg/kg/min Continuous Iv. Patient was hospitalized.

5424703-5 | Pneumonia
Patient was taking Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: pneumonia (What is pneumonia?) on Aug 16, 2007 from COLOMBIA Additional patient health information: Male patient , 60 years of age, was diagnosed with cardiac failure congestive and. Natrecor dosage: . Patient was hospitalized.

5308288-X | Dizziness, Dyspnoea, Hyperventilation, Panic Disorder
Adverse event was reported on Apr 23, 2007 by a Male patient taking Natrecor (View Usage) (Dosage: 5 Ug/kgsq One Time Dose) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 67 years of age, weighting 255.7 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dyspnoea, hyperventilation, panic disorder (What is panic disorder?). During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LONOXIN (View Lonoxin Review and Lonoxin Label ), RYTHMOL (View Rythmol Review and Rythmol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MVT (View Mvt Review and Mvt Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

5301947-4 | Hypotension
on Apr 16, 2007 Female patient from UNITED STATES , 67 years of age, weighting 335.1 lb, was diagnosed with cardiac failure congestive and was treated with Natrecor (View Usage). Patient had the following side effects: hypotension. Natrecor dosage: 6 Mcg/ml 6.9ml/hr Iv Drip. Patient was hospitalized and became disabled.

5202332-6 | Atrial Flutter
on Nov 01, 2005 Female patient from UNITED STATES , 79 years of age, weighting 85.00 lb, was diagnosed with cardiac failure congestive and was treated with Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: atrial flutter. Natrecor dosage: Intermittent Infusions. Patient was hospitalized.

5202331-4 | Blood Creatinine Increased
Patient was taking Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased on Aug 19, 2005 from UNITED STATES Additional patient health information: Male patient , 85 years of age, . Natrecor dosage: Intravenous. Patient was hospitalized.

5202330-2 | Hypotension
Adverse event was reported on Feb 02, 2006 by a Male patient taking Natrecor (View Usage) (Dosage: 1 Dose(s), 1 In 1 Total;) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 71 years of age, weighting 270.0 lb, Patient had the following side effects: hypotension.

5202328-4 | Hypotension
on Dec 15, 2005 Female patient from UNITED STATES , 70 years of age, was treated with Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: hypotension. Natrecor dosage: Intravenous. Patient was hospitalized.

5202327-2 | Overdose
on Nov 30, 2005 Female patient from UNITED STATES , 69 years of age, was diagnosed with cardiac failure congestive and was treated with Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: overdose. Natrecor dosage: 750 Ug, 1 In 4 Hour, Intravenous. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), CARVEDIOL (CARVEDILOL) (View Carvediol (carvedilol) Review and Carvediol (carvedilol) Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HUMULIN (NOVOLIN 20/80) (View Humulin (novolin 20/80) Review and Humulin (novolin 20/80) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LEVOALBUTEROL (ANTI ASTHMATICS) (View Levoalbuterol (anti-asthmatics) Review and Levoalbuterol (anti-asthmatics) Label ).

5126061-2 | Feeling Abnormal, Haematuria, Hypotension, Oxygen Saturation Decreased, Pallor, Thrombosis
Patient was taking Natrecor (View Usage). Patient had the following side effects: feeling abnormal, haematuria, hypotension, oxygen saturation decreased, pallor, thrombosis on Oct 10, 2006 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 180.8 lb, was diagnosed with cardiac failure congestive and. Natrecor dosage: 10 Ug/kg Sq Bid. During the same period patient was treated with VALSARTIN (View Valsartin Review and Valsartin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), PLAVIX (View Plavix Review and Plavix Label ), NISCIN (View Niscin Review and Niscin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ). Patient was hospitalized.

5113823-0 | Hypotension
Adverse event was reported on Sep 21, 2006 by a Male patient taking Natrecor (View Usage) (Dosage: 6ml/hr (36 Mcg/hr) Iv) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 73 years of age, weighting 146.2 lb, After Natrecor was administered, patient had the following side effects: hypotension. During the same period patient was treated with FLUID (NS) BOLUS (View Fluid (ns) Bolus Review and Fluid (ns) Bolus Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ).

5099869-X | Groin Pain, Iatrogenic Injury, Off Label Use, Procedural Complication
on Sep 06, 2006 Male patient from UNITED STATES , 81 years of age, was diagnosed with prophylaxis, renal disorder and was treated with Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: groin pain, iatrogenic injury, off label use, procedural complication. Natrecor dosage: Iv Bolus. Patient was hospitalized and became disabled.

5030019-1 | Blood Chloride Decreased, Hypoglycaemia, Unresponsive To Verbal Stimuli
on Jun 12, 2006 Female patient from UNITED STATES , weighting 104.9 lb, was diagnosed with pulmonary oedema, cardiac failure congestive and was treated with Natrecor (View Usage). Patient had the following side effects: blood chloride decreased, hypoglycaemia, unresponsive to verbal stimuli. Natrecor dosage: 28.2mcg/hr. During the same period patient was treated with LOPRESSOR (View Lopressor Review and Lopressor Label ), LASIX (View Lasix Review and Lasix Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), DOPAMINE (View Dopamine Review and Dopamine Label ).

4996631-0 | Hypoglycaemia, Unresponsive To Verbal Stimuli
Patient was taking Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: hypoglycaemia, unresponsive to verbal stimuli on Apr 28, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 104.9 lb, . Natrecor dosage: 28.2mcg/hr. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), DOPAMINE (View Dopamine Review and Dopamine Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), ZETIA (View Zetia Review and Zetia Label ).

4990217-X | Blood Glucose Decreased
Adverse event was reported on May 01, 2006 by a Female patient taking Natrecor (View Usage) (Dosage: 2mcg/kg Bolus Once Iv Bolus; 0.01mcg/kg/min Continuous Iv Drip) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 81 years of age, weighting 105.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose decreased. Patient was hospitalized.

4955842-0 | Azotaemia, Bacteraemia, Cardio-respiratory Arrest, Dyskinesia, Peripheral Coldness, Renal Failure, Shock, Skin Discolouration
on Mar 27, 2006 Female patient from UNITED STATES , 81 years of age, weighting 180.0 lb, was diagnosed with prophylaxis, renal disorder and was treated with Natrecor (View Usage). Patient had the following side effects: azotaemia, bacteraemia, cardio-respiratory arrest, dyskinesia, peripheral coldness, renal failure, shock, skin discolouration. Natrecor dosage: 1 Iv. Patient was hospitalized and became disabled.

4901905-5 | Hallucination, Visual, Infusion Related Reaction
on Feb 02, 2006 Female patient from UNITED STATES , 94 years of age, weighting 145.5 lb, was diagnosed with cardiac failure congestive and was treated with Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: hallucination, visual, infusion related reaction. Natrecor dosage: .

4852400-3 | Blood Bilirubin Increased, Hepatic Congestion, Liver Function Test Abnormal
Patient was taking Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, hepatic congestion, liver function test abnormal on Dec 06, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 196.0 lb, . Natrecor dosage: 0.01 Mcg/kg/min. During the same period patient was treated with DEMODEX (View Demodex Review and Demodex Label ), DIURIL SODIUM (View Diuril Sodium Review and Diuril Sodium Label ), POTASSIUM (View Potassium Review and Potassium Label ), REGLAN (View Reglan Review and Reglan Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PRIMACOR (View Primacor Review and Primacor Label ), DOBUTAMINE (View Dobutamine Review and Dobutamine Label ).

4843853-5 | Blood Creatinine Increased
Adverse event was reported on Nov 30, 2005 by a Female patient taking Natrecor (View Usage) (Dosage: ;;0;0) . Location: UNITED STATES , 74 years of age, Patient had the following side effects: blood creatinine increased. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ).

4822012-6 | Blood Bilirubin Increased, Hepatic Congestion
on Nov 02, 2005 Male patient from UNITED STATES , 50 years of age, was treated with Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: blood bilirubin increased, hepatic congestion. Natrecor dosage: 0.01 Mcg/kg/min.

4808525-1 | Cardiac Arrest
on Oct 14, 2005 Male patient from UNITED STATES , weighting 177.0 lb, was diagnosed with chest pain (What is chest pain?) and was treated with Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Natrecor dosage: . During the same period patient was treated with ATROVASTATIN (View Atrovastatin Review and Atrovastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

4790951-0 | Hypotension
Patient was taking Natrecor (View Usage). Patient had the following side effects: hypotension on Oct 05, 2005 from UNITED STATES Additional patient health information: Male patient , 51 years of age, weighting 219.4 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), transplant evaluation and. Natrecor dosage: 0.03 Mcg/kg/min Hourly Iv Drip. During the same period patient was treated with FLOLAN (View Flolan Review and Flolan Label ), MILRINONE (View Milrinone Review and Milrinone Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LASIX (View Lasix Review and Lasix Label ), CAPOTEN (View Capoten Review and Capoten Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).

4784550-4 | Cardiac Arrest, Cardiomyopathy, Coronary Artery Stenosis, Dementia, Sinus Bradycardia, Vascular Encephalopathy, Ventricular Fibrillation, Ventricular Tachycardia
Adverse event was reported on Sep 23, 2005 by a Male patient taking Natrecor (View Usage) (Dosage: ) was diagnosed with chest pain (What is chest pain?) and. Location: UNITED STATES , weighting 177.0 lb, After Natrecor was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), cardiomyopathy (What is cardiomyopathy?), coronary artery stenosis, dementia (What is dementia?), sinus bradycardia, vascular encephalopathy, ventricular fibrillation, ventricular tachycardia. During the same period patient was treated with ATROVASTATIN (View Atrovastatin Review and Atrovastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

4784549-8 | Acute Myeloid Leukaemia
on Sep 21, 2005 Male patient from UNITED STATES , 83 years of age, was treated with Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia. Natrecor dosage: .

4760699-7 |
on Aug 24, 2005 Female patient from ARGENTINA , 63 years of age, weighting 121.3 lb, was treated with Natrecor (View Usage). . Natrecor dosage: 0.01 Mcg/kg/min. During the same period patient was treated with MILRINONE (View Milrinone Review and Milrinone Label ), DOPAMINE (View Dopamine Review and Dopamine Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), LEVOSIMENDAN (View Levosimendan Review and Levosimendan Label ).

4746048-9 | Blood Creatinine Increased, Blood Urea Increased, Brain Natriuretic Peptide Increased, Diabetes Mellitus
Patient was taking Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: blood creatinine increased, blood urea increased, brain natriuretic peptide increased, diabetes mellitus on Aug 02, 2005 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 170.0 lb, . Natrecor dosage: 8.3 Ml/hr Over 5 Hours.. During the same period patient was treated with KCLOR (View Kclor Review and Kclor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LASIX (View Lasix Review and Lasix Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

4745713-7 | Blood Pressure Decreased, Confusional State
Adverse event was reported on Aug 15, 2005 by a Male patient taking Natrecor (View Usage) (Dosage: Load 2 Mcg /kg, 0.01 Mg/kg /min) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 80 years of age, weighting 163.6 lb, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, confusional state. During the same period patient was treated with ZAROXOLYN (View Zaroxolyn Review and Zaroxolyn Label ), LASIX (View Lasix Review and Lasix Label ).

4745200-6 | Blood Creatinine Increased, Blood Urea Increased, Brain Natriuretic Peptide Increased, Diabetes Mellitus
on Aug 02, 2005 Male patient from UNITED STATES , 79 years of age, weighting 170.0 lb, was treated with Natrecor (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, brain natriuretic peptide increased, diabetes mellitus. Natrecor dosage: 8.3 Ml/hr Over 5 Hours.. During the same period patient was treated with KCLOR (View Kclor Review and Kclor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LASIX (View Lasix Review and Lasix Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

4736285-1 | Cardiac Failure Congestive, Renal Failure
on Aug 05, 2005 Male patient from UNITED STATES , 84 years of age, weighting 110.0 lb, was diagnosed with cardiac failure congestive and was treated with Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: cardiac failure congestive, renal failure. Natrecor dosage: 2 Mcg/kg Bolus 0.01 Mcg/kg/ Min X 48 H. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ).

4726950-4 | Cardiac Failure, Diarrhoea, Haematochezia
Patient was taking Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, diarrhoea, haematochezia on Jul 21, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 292.3 lb, . Natrecor dosage: . During the same period patient was treated with BUMEX (View Bumex Review and Bumex Label ), TRICOR (View Tricor Review and Tricor Label ), LASIX (View Lasix Review and Lasix Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ), AVANDIA (View Avandia Review and Avandia Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4726153-3 | Cardiac Failure Congestive, Endocarditis Bacterial, Injection Site Reaction, Mitral Valve Incompetence, Phlebitis, Renal Failure Chronic, Sepsis, Skin Necrosis
Adverse event was reported on Jul 25, 2005 by a Female patient taking Natrecor (View Usage) (Dosage: 2 Mcg/kg, Continuous Infusion Of 0.01 Mcg/kg/min.) . Location: UNITED STATES , 78 years of age, weighting 124.6 lb, Patient had the following side effects: cardiac failure congestive, endocarditis bacterial, injection site reaction, mitral valve incompetence, phlebitis, renal failure chronic, sepsis (What is sepsis?), skin necrosis. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), FUROSEMIDE (Administered In Er At 10:30 Hours.) (View Furosemide Review and Furosemide Label ).

4722813-9 | Cardiac Failure Congestive, Thrombocytopenia
on Jul 18, 2005 Female patient from UNITED STATES , weighting 122.0 lb, was treated with Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: cardiac failure congestive, thrombocytopenia. Natrecor dosage: 2 Mcg/kg Bolus And 0.01 Mcg/kg/min Infusion. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ALTACE (View Altace Review and Altace Label ), ZOCOR (View Zocor Review and Zocor Label ), LASIX (View Lasix Review and Lasix Label ), SINGULAIR (View Singulair Review and Singulair Label ), TYLENOL (View Tylenol Review and Tylenol Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), COREG (View Coreg Review and Coreg Label ). Patient was hospitalized.

4716070-7 |
on Jul 07, 2005 Male patient from ARGENTINA , weighting 244.7 lb, was treated with Natrecor (View Usage). . Natrecor dosage: .

4699036-5 | Blood Pressure Decreased, Oxygen Saturation Decreased, Skin Discolouration
Patient was taking Natrecor (View Usage). Patient had the following side effects: blood pressure decreased, oxygen saturation decreased, skin discolouration on Jun 23, 2005 from Additional patient health information: Female patient , 80 years of age, weighting 136.0 lb, was diagnosed with cardiac failure congestive, dyspnoea and. Natrecor dosage: 2 Micrograms Kilogram Intravenou.

4682301-5 | Asthma, Blood Pressure Increased, Blood Urea Increased, Hypocalcaemia, Influenza
Adverse event was reported on May 23, 2005 by a Female patient taking Natrecor (View Usage) (Dosage: Infusion) . Location: , weighting 234.0 lb, After Natrecor was administered, patient had the following side effects: asthma (What is asthma?), blood pressure increased, blood urea increased, hypocalcaemia, influenza. During the same period patient was treated with TUMS (View Tums Review and Tums Label ). Patient was hospitalized.

4678502-2 | Thrombocytopenia
on May 21, 2005 Female patient from , 73 years of age, was treated with Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Natrecor dosage: 2 Mcg/kg Bolus And 0.01 Mcg/kg/min Infusion. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ALTACE (View Altace Review and Altace Label ), ZOCOR (View Zocor Review and Zocor Label ), LASIX (View Lasix Review and Lasix Label ), SINGULAIR (View Singulair Review and Singulair Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), COREG (View Coreg Review and Coreg Label ). Patient was hospitalized.

4677803-1 | Injection Site Reaction, Phlebitis, Sepsis
on May 16, 2005 Female patient from , 78 years of age, weighting 124.6 lb, was treated with Natrecor (View Usage). Patient had the following side effects: injection site reaction, phlebitis, sepsis (What is sepsis?). Natrecor dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

4667532-2 | Blood Glucose Increased, Diabetes Mellitus Inadequate Control, Insulin Resistance, Pneumonia
Patient was taking Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: blood glucose increased, diabetes mellitus inadequate control, insulin resistance, pneumonia (What is pneumonia?) on May 11, 2005 from Additional patient health information: Female patient , weighting 155.0 lb, . Natrecor dosage: . During the same period patient was treated with STARLIX (View Starlix Review and Starlix Label ), XALANTAN (1 Gtt In Both Eyes) (View Xalantan Review and Xalantan Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), DIOVAN (View Diovan Review and Diovan Label ), ALBUTEROL (1 Puff Every 6 Hours) (View Albuterol Review and Albuterol Label ), PROTONIX (View Protonix Review and Protonix Label ), TYLENOL (CAPLET) (As Necessary Twice Daily) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), COREG (View Coreg Review and Coreg Label ). Patient was hospitalized.

4636492-2 | Cardiac Arrest, Hypotension, Infusion Site Reaction
Adverse event was reported on Apr 14, 2005 by a Male patient taking Natrecor (View Usage) (Dosage: 138 Mcg Iv Bolus) was diagnosed with cardiac failure congestive and. Location: , 85 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hypotension, infusion site reaction. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ZAROXOLYN (View Zaroxolyn Review and Zaroxolyn Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYRALAZINE (View Hyralazine Review and Hyralazine Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).

4614784-0 | Asthma, Hypocalcaemia, Influenza
on Mar 11, 2005 Female patient from , weighting 234.0 lb, was treated with Natrecor (View Usage). Patient had the following side effects: asthma (What is asthma?), hypocalcaemia, influenza. Natrecor dosage: Infusion. During the same period patient was treated with TUMS (View Tums Review and Tums Label ). Patient was hospitalized.

4597624-8 | Asthenia, Diarrhoea, Frequent Bowel Movements, Hyperhidrosis, Muscle Spasms, Nausea
on Feb 15, 2005 Female patient from , weighting 164.0 lb, was treated with Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: asthenia, diarrhoea, frequent bowel movements, hyperhidrosis, muscle spasms, nausea (What is nausea?). Natrecor dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), INDERAL (View Inderal Review and Inderal Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LASIX (View Lasix Review and Lasix Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

4588413-9 | Hypotension
Patient was taking Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension on Feb 15, 2005 from Additional patient health information: Male patient , weighting 227.0 lb, was diagnosed with cardiac failure congestive, pulmonary oedema and. Natrecor dosage: 1 Mcg/kg Bol Once Intravenou; 0.01 Mcg/kg/ Continuous Intravenou. Patient was hospitalized.

4588408-5 | Blood Pressure Decreased, Blood Sodium Decreased
Adverse event was reported on Feb 15, 2005 by a Female patient taking Natrecor (View Usage) (Dosage: 2 Mcg/kg Once Intravenou; 0.01mcg/kg/m Continuous Intravenou) was diagnosed with cardiac failure congestive, pulmonary oedema and. Location: , weighting 270.0 lb, Patient had the following side effects: blood pressure decreased, blood sodium decreased. Patient was hospitalized.

4580160-2 | Perforated Ulcer, Weight Decreased
on Feb 08, 2005 Male patient from , 49 years of age, was treated with Natrecor (View Usage). After Natrecor was administered, patient had the following side effects: perforated ulcer, weight decreased. Natrecor dosage: .

4569170-9 | Thrombocytopenia
on Jan 26, 2005 Female patient from , 42 years of age, weighting 176.0 lb, was treated with Natrecor (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Natrecor dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ZYVOX (View Zyvox Review and Zyvox Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

4567964-7 | Thrombocytopenia
Patient was taking Natrecor (View Usage). Patient had the following side effects: thrombocytopenia on Jan 26, 2005 from Additional patient health information: Female patient , 42 years of age, weighting 176.0 lb, . Natrecor dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ZYVOX (View Zyvox Review and Zyvox Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.